PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:05 AM ET

Sponsor Check › Person

EB
No photo found yet (own website and image search run after this page is viewed)

Erick Berglund

Named as an officer, director or promoter on SEC Form D filings · NY · Apr 12, 2018 → Jan 22, 2024

1deal (issuers)
$3.28Mreported sold
15investors
5Form D filings
2018–2024years on file

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:42 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Erick Berglund is listed as a director and promoter on 5 SEC Form D filings by 1 issuer between Apr 2018 and Jan 2024: Intrommune Therapeutics, Inc. (New York, NY — biotechnology — 2018–2024; $3.28M reported sold to 15 investors).

What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.

Listed alongside Michael Nelson (4 shared filings), William Reisacher (4 shared filings), Hemanshu Pandya (2 shared filings), Jonathan Rich (2 shared filings), Anthony Robinson (1 shared filing) and 1 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Erick. Each name links to their own page.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.

What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared 5 public filings for Erick Berglund and found 8 differences, 1 worth asking the sponsor about: Form D filed 677 days after the first sale; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Erick Berglund has not run yet — it is joining a line of 6,097 names; searches run around the clock at the hosts' allowed rate. Searched so far: 27 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:42 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Erick Berglund..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:42 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

8 differences found between the filings for Erick Berglund — 1 worth asking about (compared 5 filings on Oct 24, 2026)

Worth asking · Mar 16, 2022 – Jan 22, 2024

Form D filed 677 days after the first sale — Intrommune Therapeutics, Inc.

The filing says the first sale was Mar 16, 2022. The Form D was filed Jan 22, 2024 — 677 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 662 days past that.

What this means The notice went in months after money was taken in. Late notices are common and carry no penalty by themselves, but it is fair to ask the sponsor why the paperwork lagged.

Sources
Note · Dec 6, 2023 – Jan 22, 2024

Form D filed 47 days after the first sale — Intrommune Therapeutics, Inc.

The filing says the first sale was Dec 6, 2023. The Form D was filed Jan 22, 2024 — 47 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 32 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Sources
Note · Apr 12, 2018 – Jun 23, 2021

Erick Berglund's role changed at Intrommune Therapeutics, Inc.: director, promoter → director

The Apr 12, 2018 filing lists Erick Berglund as director, promoter; the Jun 23, 2021 Form D lists director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Sources
Note · Dec 6, 2023 – Jan 22, 2024

No amendment in the last 12 months on an offering that may still be open — Intrommune Therapeutics, Inc. (latest filing Jan 22, 2024)

The latest filing for this offering is dated Jan 22, 2024 (first sale Dec 6, 2023). It reports $210,000 sold of $10,000,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · Jul 2, 2021 – Jul 8, 2021

No amendment in the last 12 months on an offering that may still be open — Intrommune Therapeutics, Inc. (latest filing Jul 8, 2021)

The latest filing for this offering is dated Jul 8, 2021 (first sale Jul 2, 2021). It reports $68,043 sold of $20,000,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · Apr 12, 2018

No amendment in the last 12 months on an offering that may still be open — Intrommune Therapeutics, Inc. (latest filing Apr 12, 2018)

The latest filing for this offering is dated Apr 12, 2018 (first sale Apr 12, 2018). It reports $0 sold of $2,000,100 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · Apr 12, 2018

Formed in 2021 per the latest filing, but activity is dated 2018 — Intrommune Therapeutics, Inc.

The issuer's latest filing says it was formed in 2021. The Apr 12, 2018 filing says the first sale was Apr 12, 2018 — before that year.

What this means A company cannot sell before it exists, so one of the two dates is likely a typo on the form. Ask the sponsor for the formation document.

Sources
Note · Jun 23, 2021 – Jul 8, 2021

Minimum investment changed between filings — Intrommune Therapeutics, Inc.

The Jun 23, 2021 filing lists a minimum of $5,000; the Jul 8, 2021 Form D/A lists $1,000.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

1 of 4 offerings reports sales commissions totalling $98,005; 0 report finder's fees; 0 report proceeds to related persons. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Jan 22, 2024 D
Intrommune Therapeutics, Inc.
File 021-503082
$0$0$0None listed on this filingEDGAR ↗
Jan 22, 2024 D
Intrommune Therapeutics, Inc.
File 021-503083
$0$0$0None listed on this filingEDGAR ↗
Jul 8, 2021 D/A
Intrommune Therapeutics, Inc.
File 021-403944
$0$0$0 (est.)None listed on this filingEDGAR ↗
Apr 12, 2018 D
Intrommune Therapeutics, Inc.
File 021-310049
$98,005 (est.)$0$0 (est.)LIVINGSTON SECURITIES, LLC BrokerCheck CRD 147364 ↗
via LIVINGSTON SECURITIES, LLC (CRD 147364 ↗)
EDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 1

Every issuer that named Erick Berglund on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Biotechnology

Intrommune Therapeutics, Inc.

New York, NY · Apr 12, 2018 → Jan 22, 2024 · 5 filings
  • Jan 22, 2024 · D · $210,000 sold of $10,000,000 · 7 investors · min. $1,000 · role: Director EDGAR ↗
  • Jan 22, 2024 · D · $3,278,840 sold of $3,278,840 · 15 investors · min. $20,000 · role: Director EDGAR ↗
  • Jul 8, 2021 · D/A · $68,043 sold of $20,000,000 · 6 investors · min. $1,000 · role: Director EDGAR ↗
  • Jun 23, 2021 · D · $0 sold of $20,000,000 · 0 investors · min. $5,000 · role: Director EDGAR ↗
  • Apr 12, 2018 · D · $0 sold of $2,000,100 · 0 investors · min. $99 · role: Director, Promoter (There is no clarification needed.) EDGAR ↗

Raised $3.28M from 15 investors (33% of the $10M target) as of the latest filing. Erick is listed as director, promoter on 5 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

People around Erick 6

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

MN
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Nelson

Director, Promoter, Executive Officer · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Erick Berglund. Their page shows their other deals.

WR
No photo found yet (own website and image search run after this page is viewed)
Person

William Reisacher

Director · 4 shared filings (1 issuer)

Listed on the same filings as Erick Berglund. Their page shows their other deals.

JR
No photo found yet (own website and image search run after this page is viewed)
Person

Jonathan Rich

Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Erick Berglund. Their page shows their other deals.

HP
No photo found yet (own website and image search run after this page is viewed)
Person

Hemanshu Pandya

Director · 2 shared filings (1 issuer)

Listed on the same filings as Erick Berglund. Their page shows their other deals.

AR
No photo found yet (own website and image search run after this page is viewed)
Person

Anthony Robinson

Promoter · 1 shared filing (1 issuer)

Listed on the same filings as Erick Berglund. Their page shows their other deals.

NM
No photo found yet (own website and image search run after this page is viewed)
Person

Nelson Michael

Executive Officer, Director · 1 shared filing (1 issuer)

Listed on the same filings as Erick Berglund. Their page shows their other deals.

Registrations and other filings

Adviser registration (Form ADV)

None of the 1 issuer this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

7 Regulation Crowdfunding filings — tap to see each filing
SourceFiledFormIssuerAmount offered (as reported)Amount sold (as reported)Matched on
EDGAR ↗Apr 28, 2021
File 020-24167
Regulation Crowdfunding termination of reporting (Form C-TR)
Reporting terminated
ZENII, LLC
New York, NY
Not reportedNot reported on this formsigner name on this filing (Erick Berglund) + listed as a related person on Form D filings of the same issuer (CIK 1736977) · 85%
EDGAR ↗Jun 15, 2020
File 020-24167
Regulation Crowdfunding annual report (Form C-AR)
Annual report filed
ZENII, LLC
NEW YORK, NY
Not reportedNot reported on this formsigner name on this filing (Erick Berglund) + listed as a related person on Form D filings of the same issuer (CIK 1736977) · 85%
EDGAR ↗Apr 30, 2019
File 020-24167
Regulation Crowdfunding annual report (Form C-AR)
Annual report filed
ZENII, LLC
NEW YORK, NY
Not reportedNot reported on this formsigner name on this filing (Erick Berglund) + listed as a related person on Form D filings of the same issuer (CIK 1736977) · 85%
EDGAR ↗Jul 6, 2018
File 020-24167
Regulation Crowdfunding progress update (Form C-U)
Progress update filed · deadline Jun 29, 2018
ZENII, LLC
New York, NY
$10,000 target · $1,070,000 maximum
via NetCapital Funding Portal Inc. (CRD 283596 · FINRA funding portals ↗)
Not reported on this formsigner name on this filing (Erick Berglund) + listed as a related person on Form D filings of the same issuer (CIK 1736977) · 85%
EDGAR ↗Jun 12, 2018
File 020-24167
Regulation Crowdfunding offering — amendment (Form C/A)
Amendment filed · deadline Jun 29, 2018
ZENII, LLC
New York, NY
$10,000 target · $1,070,000 maximum
via NetCapital Funding Portal Inc. (CRD 283596 · FINRA funding portals ↗)
Not reported on this formsigner name on this filing (Erick Berglund) + listed as a related person on Form D filings of the same issuer (CIK 1736977) · 85%
EDGAR ↗Jun 7, 2018
File 020-24167
Regulation Crowdfunding offering — amendment (Form C/A)
Amendment filed · deadline Jun 17, 2018
ZENII, LLC
New York, NY
$10,000 target · $1,070,000 maximum
via NetCapital Funding Portal Inc. (CRD 283596 · FINRA funding portals ↗)
Not reported on this formsigner name on this filing (Erick Berglund) + listed as a related person on Form D filings of the same issuer (CIK 1736977) · 85%
EDGAR ↗Apr 12, 2018
File 020-24167
Regulation Crowdfunding offering (Form C)
Offering filed · deadline Jun 17, 2018
ZENII, LLC
New York, NY
$10,000 target · $1,070,000 maximum
via NetCapital Funding Portal Inc. (CRD 283596 · FINRA funding portals ↗)
Not reported on this formsigner name on this filing (Erick Berglund) + listed as a related person on Form D filings of the same issuer (CIK 1736977) · 85%

Amounts are as reported by the issuer on the form; Regulation Crowdfunding forms report a target and maximum, not sales. Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Erick Berglund by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 1 issuer this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Erick Berglund is listed on, as found in their SEC filings (Form C, Reg A, Form ADV, EDGAR profile) or on the sponsor's own site; none belongs to the person unless the sponsor's site says so. Checked Oct 24, 2026.

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (New York, NY). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Found on the sponsor's own site

intrommune.com ↗ found on Intrommune Therapeutics, Inc. (intrommune.com — Form C 0001104659-21-056317 (issuer website as filed))

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Erick Berglund appears on a new Form D, or when a court case or SEC action is matched to them. See plans →